As you know, atopic dermatitis (AD) is a chronic, severe form of eczema that is marked by the appearance of dry, red, and itchy skin. Most commonly, AD affects the cheeks, arms, and legs. There are times when AD can flare up and symptoms worsen, which can lead to more-intense itching and more open sores.
But these painful, irritating symptoms just scratch the surface of what it’s like to live with AD. There’s the embarrassment that comes with exposing the red, patchy skin, or the added irritation that comes from wearing long sleeves to cover it up.
It can be frustrating searching for the right treatment option for you or your child – especially if you’ve tried many and none have worked. However, right now, research is underway on an investigational medication for AD, and you or your child may be able to take part.
About the ADvocate Studies:
The purpose of the ADvocate Studies is to evaluate the safety and effectiveness of an injectable investigational medication for moderate to severe atopic dermatitis. Eligible participants for these studies must:
- Be an adult or adolescent, 12 years of age or older, weigh at least 40 Kg (88 lb)
- Have chronic atopic dermatitis for ateast one year.
- Have a history of inadequate response to topical treatments for atopic dermatitis
Talk to us at Foxhall Research Center (202-838-3016) or email firstname.lastname@example.org and visit ADvocatestudies.com to learn more.